Prospect Biosystems logo
photo courtesy National Cancer Institute

Prospect Biosystems' Edge Technology is a major breakthrough, non-denaturing front-end sample fractionation and separation methodology. It comprises a stepwise extraction of a particle mixture using extracting media of increasing densities.

Prospect Biosystems' technology enables scientists involved in the discovery and development of pharmaceutical targets, diagnostics and therapeutics to:

  • Rapidly characterize differences between diseased and healthy tissue;
  • Significantly enrich low-abundance proteins from their crude extracts;
  • Increase the reliability and specificity of downstream analyses;
  • Easily identify and evaluate predictive, diagnostic and prognostic biomarkers;
  • Facilitate clinical outcome prediction through the use of surrogate biomarkers, and;
  • Develop rapid biomarker tests for clinical diagnosis and management.

Prospectů."explore for useful or valuable things or substances"

Partners with:
njit logo
©2010 Prospect Biosystems, Inc.